AC
PRVL

Athanor Capital’s Prevail Therapeutics Inc. Common Stock PRVL Stock Holding History

Athanor Capital’s Portfolio PRVL Stock Details PRVL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-19,347
Closed -$288K – 709
2020
Q2 		$288K Buy
+19,347
New +$288K 0.01% 408